Paxman (OTCPK:PXMB.F) - Stock Price, News & Analysis

PXMB.F Stock Overview

Develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. More details

PXMB.F fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	6/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 67.5% below our estimate of its fair value

Earnings are forecast to grow 57.23% per year

Became profitable this year

Risk Analysis

Shares are highly illiquid

High level of non-cash earnings

Does not have a meaningful market cap ($1B)

Paxman AB (publ) Competitors

Kewaunee Scientific

NasdaqGM:KEQU

US$122.3m

FONAR

NasdaqCM:FONR

US$95.3m

Sensus Healthcare

NasdaqCM:SRTS

US$146.5m

Baird Medical Investment Holdings

NasdaqCM:BDMD

US$87.6m

Price History & Performance

Summary of all time highs, changes and price drops for Paxman
Historical stock prices
Current Share Price	SEK 3.50
52 Week High	SEK 3.50
52 Week Low	SEK 2.80
Beta	0.84
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	-42.81%
5 Year Change	n/a
Change since IPO	-47.68%

Recent updates

Shareholder Returns

	PXMB.F	US Medical Equipment	US Market
7D	0%	1.7%	0.3%
1Y	n/a	21.4%	31.1%

Return vs Industry: Insufficient data to determine how PXMB.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how PXMB.F performed against the US Market.

Price Volatility

Is PXMB.F's price volatile compared to industry and market?
PXMB.F volatility
PXMB.F Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.0%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.8%
10% least volatile stocks in US Market	3.1%

Stable Share Price: PXMB.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PXMB.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1996	94	Richard Paxman	paxmanscalpcooling.com

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device.

Paxman AB (publ) Fundamentals Summary

How do Paxman's earnings and revenue compare to its market cap?
PXMB.F fundamental statistics
Market cap	US$97.12m
Earnings (TTM)	US$2.28m
Revenue (TTM)	US$22.37m

42.7x

P/E Ratio

4.3x

P/S Ratio

Is PXMB.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PXMB.F income statement (TTM)
Revenue	SEK 235.60m
Cost of Revenue	SEK 78.32m
Gross Profit	SEK 157.29m
Other Expenses	SEK 133.32m
Earnings	SEK 23.97m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 21, 2024

Earnings per share (EPS)	1.26
Gross Margin	66.76%
Net Profit Margin	10.17%
Debt/Equity Ratio	12.6%

How did PXMB.F perform over the long term?

See historical performance and comparison

Paxman OTCPK:PXMB.F Stock Report